HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase.

Abstract
Phosphorylation of insulin receptor substrate-1 (IRS-1) on serine residues has been recognized as a mechanism responsible for a diminution of insulin action and insulin resistance. Potential approaches to improve insulin sensitivity may include interference with and/or reduction in expression of certain signaling intermediates that participate in the pathogenesis of insulin resistance. In this study, we transduced fully differentiated 3T3-L1 adipocytes with a constitutively active myristoylated Akt that led to hyperactivation of mammalian target of rapamycin and p70 S6 kinase (S6K1), increased serine phosphorylation of IRS-1, and reduction in insulin-stimulated phosphatidylinositol (PI) 3-kinase activity and glucose transport. We then reduced expression of the PI 3-kinase regulatory subunit, p85alpha, or expression of S6K1 kinase using small interfering RNA transfections, which led to a reduction in p85alpha expression of 70% at 48 h (P < 0.05) and S6K1 of 49% (P < 0.05). Reduction in expression of either p85alpha or S6K1 achieved with small interfering RNA in the presence of myristoylated Akt rescued 3T3-L1 adipocytes from the insulin resistance induced by serine phosphorylation of IRS-1 and completely restored insulin-stimulated activation of PI 3-kinase and glucose uptake. We conclude that reduction in expression of p85alpha or S6K1 could represent therapeutic targets to mitigate insulin resistance.
AuthorsRebecca Adochio, J Wayne Leitner, Reed Hedlund, Boris Draznin
JournalEndocrinology (Endocrinology) Vol. 150 Issue 3 Pg. 1165-73 (Mar 2009) ISSN: 1945-7170 [Electronic] United States
PMID18948408 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Insulin Receptor Substrate Proteins
  • Irs1 protein, mouse
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Subunits
  • RNA, Small Interfering
  • Serine
  • Protein Kinases
  • mTOR protein, mouse
  • Oncogene Protein v-akt
  • Ribosomal Protein S6 Kinases, 90-kDa
  • Rps6ka1 protein, mouse
  • TOR Serine-Threonine Kinases
Topics
  • 3T3-L1 Cells
  • Adipocytes (drug effects, metabolism, pathology)
  • Animals
  • Genetic Therapy (methods)
  • Insulin Receptor Substrate Proteins (metabolism)
  • Insulin Resistance (genetics, physiology)
  • Mice
  • Oncogene Protein v-akt (genetics, metabolism)
  • Phosphatidylinositol 3-Kinases (metabolism, physiology)
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation (genetics)
  • Protein Kinases (metabolism)
  • Protein Subunits (metabolism, physiology)
  • RNA, Small Interfering (pharmacology)
  • Ribosomal Protein S6 Kinases, 90-kDa (antagonists & inhibitors, metabolism)
  • Serine (metabolism)
  • Signal Transduction (genetics)
  • TOR Serine-Threonine Kinases
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: